Pharma News – CVS Taking Steps To Counter Perceived Amazon Threat

MLT CreativeIndustry News

With pharmacies not certain of whether or not Amazon will expand into the prescription drug arena, some are taking steps in an effort to preserve their business and compete in the event the e-tail giant does venture into this market. In recent pharma news, CVS Health has announced that in 2018 it will begin offering same-day delivery of prescription drugs …

Evidence Of Amazon’s Intention To Get Into Pharmaceutical Industry

MLT CreativeIndustry News

More and more, it’s looking as though e-commerce giant, Amazon, has strong intentions of getting into the pharmaceutical drug industry as it continues to obtain approval for wholesale distributorship of pharmaceuticals in a mounting number of states. How will this impact the pharmaceutical industry? According to recent reports, Amazon would need a pharmacy license to sell medical devices or prescription …

Pharma News – GlaxoSmithKline Gets FDA Okay For Shingles Vaccine

MLT CreativeNews

Recently in pharma news, it was announced that the FDA has approved a new shingles vaccine from GlaxoSmithKline, designed to immunize those aged 50 or older against the shingles virus. The new vaccine, Shingrix, is said to be more effective than the vaccine that has been used in recent years, according to an FDA panel expert. This was in reference …

Packaging Coders – Is Your Packaging Retail-Ready?

MLT CreativeNews

You’re probably familiar with retail-ready packaging if you’re a manufacturer of retail products supplied to big box stores such as Kroger or Walmart, but are you using it? Because retailers prefer this secondary packaging, it’s in most manufacturers’ best interest to consider it, because it eliminates some of the headaches and costs for retailers. For example, when secondary packaging, such …

Pfizer Considers Sale Or Spin-Off Of Consumer Healthcare Business

MLT CreativeNews

Recently it was announced that, as health-conscious consumers and an aging population control increasing demand for self-medication, Pfizer is considering the sale or spin-off of the company’s consumer healthcare business, to the tune of $15 billion. In recent years, deal-making has become more pronounced as consumers’ desire for self-medication increases, whether in lip balms, headache medications, vitamins, or other OTC …